Skip to content

Buy Ratings

“Solid Alpha Potential”: 5 Stocks Under $10 For Aggressive Investors – Including An Intriguing Biotech Play

“These are five stocks for aggressive investors looking to get share count leverage on companies that have sizable upside potential,” says the author of today’s article of the five stocks he highlights – all of which have Buy ratings at major firms and are trading under the $10 level. For these five stocks –which include an intriguing biotech play with… 

4 Biotech Stocks To Buy, According To UBS

UBS just initiated coverage on nine biotech stocks, four of which its analysts have given ‘Buy’ ratings – and two of those, the analysts believe, could soar by more than 50%. For these four biotech stocks that investors should buy, according to UBS, as well as the five biotech stocks that the firm initiated coverage on at a ‘Neutral’ rating,…